AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2015
Dec 28, 2015
32870_dirs_2015-12-28_3cc6b842-0735-4af0-836b-123349bed9dd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-12-23
Reporting Person: Abdun-Nabi Daniel (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-23 | Common Stock | M | 40354 | $18.90 | Acquired | 225722 | Direct |
| 2015-12-23 | Common Stock | S | 40354 | $38.99 | Disposed | 185368 | Direct |
| 2015-12-24 | Common Stock | M | 22855 | $18.90 | Acquired | 208223 | Direct |
| 2015-12-24 | Common Stock | S | 22855 | $39.17 | Disposed | 185368 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-23 | Stock Option | $18.90 | M | 40354 | Disposed | 2019-03-09 | Common Stock (40354) | Direct |
| 2015-12-24 | Stock Option | $18.90 | M | 22855 | Disposed | 2019-03-09 | Common Stock (22855) | Direct |
Footnotes
F1: Consists of an option granted under the company's stock incentive plan on March 10, 2009.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi.
F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.79 to $39.11, inclusive.
F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.99 to $39.48, inclusive.
F5: The option vested in three equal installments in March 2010, 2011 and 2012.